mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change Y02A50/30- Against vector-borne diseases, e.g.Y02A50/00- TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g.Y02A- TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE.Y02- TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE.Y- GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS AND DIGESTS.A61K2236/55- Liquid-liquid separation Phase separation.A61K2236/50- Methods involving additional extraction steps.A61K2236/33- Extraction of the material involving extraction with hydrophilic solvents, e.g.A61K2236/30- Extraction of the material.

A61K2236/00- Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g.

B01D11/02- Solvent extraction of solids.

B01- PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL.fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. A61K31/352- Heterocyclic compounds having oxygen as the only ring hetero atom, e.g.fungichromin having six-membered rings with one oxygen as the only ring hetero atom A61K31/35- Heterocyclic compounds having oxygen as the only ring hetero atom, e.g.A61K31/335- Heterocyclic compounds having oxygen as the only ring hetero atom, e.g.A61K31/00- Medicinal preparations containing organic active ingredients.A61K36/185- Magnoliopsida (dicotyledons).A61K36/00- Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g.A61K- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES.A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Constance Therapeutics Inc filed Critical Constance Therapeutics Inc Publication of EP3250200A1 publication Critical patent/EP3250200A1/en Publication of EP3250200A4 publication Critical patent/EP3250200A4/en Status Pending legal-status Critical Current Links Original Assignee Constance Therapeutics Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Constance FINLEY Luke MCKEE Haley POOLE BESTWICK Paul Roethle Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number EP16744179.9A Other languages German ( de) Info Publication number EP3250200A1 EP3250200A1 EP16744179.9A EP16744179A EP3250200A1 EP 3250200 A1 EP3250200 A1 EP 3250200A1 EP 16744179 A EP16744179 A EP 16744179A EP 3250200 A1 EP3250200 A1 EP 3250200A1 Authority EP European Patent Office Prior art keywords cannabis oil extract vitamin strain Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents Methods for preparation of cannabis oil extracts and compositions Google Patents EP3250200A1 - Methods for preparation of cannabis oil extracts and compositions EP3250200A1 - Methods for preparation of cannabis oil extracts and compositions

Monkey paw weed strain